Zika Virus Infection
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, the ZIKV infection signature revealed the downregulation of ALDH5A1 and CHML, genes implicated in neurological (cognitive impairment, expressive language deficit, and mild ataxia) and ophthalmic (choroideremia) disorders, respectively.
|
30046058 |
2018 |
Writer's Cramp
|
0.300 |
Biomarker
|
disease |
CTD_human |
Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency.
|
17438226 |
2007 |
Tumor Cell Invasion
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
The accumulation of HBA metabolites caused by HGSOC was also associated with reduced expression of succinic semialdehyde dehydrogenase (encoded by ALDH5A1), and with the presence of an epithelial-to-mesenchymal transition gene signature, implying a role for these metabolic alterations in cancer cell migration and invasion.
|
26685161 |
2016 |
Tuberculosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In samples of 23 patients undergoing intensive phase TB therapy for 4 weeks, we identified drug-induced host-metabolome variations before and at repeated time intervals post-treatment: (1) an overall reduction in the oxidative stress levels over the course of TB treatment; (2) a time-dependent induction and inhibition of several enzymes in response to the drugs (CYP2E1, CYP3A4, alcohol dehydrogenase, and aminocarboxymuconate-semialdehyde decarboxylase), and altered oxidative stress levels (aconitase, formylglycine-generating enzyme, α-ketoglutarate dehydrogenase, and succinate-semialdehyde dehydrogenase); (3) an upregulated urea cycle; and (4) altered insulin production.
|
31613685 |
2019 |
Tonic - clonic seizures
|
0.110 |
Biomarker
|
disease |
BEFREE |
Murine succinate semialdehyde dehydrogenase (SSADH) deficiency (OMIM 271980; EC 1.2.1.24), a model of the corresponding human disorder, displays 100% mortality at weeks 3-4 of life, associated with lethal tonic-clonic seizures.
|
15093183 |
2004 |
Tonic - clonic seizures
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
Biomarker
|
disease |
BEFREE |
Deficiency in ALDH5A1 causes 4-hydroxybutyric aciduria.
|
10971205 |
2000 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: increased accuracy employing DNA, enzyme, and metabolite analyses.
|
11243727 |
2001 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Succinic Semialdehyde Dehydrogenase Deficiency in a Chinese Boy: A Novel ALDH5A1 Mutation With Severe Phenotype.
|
25122112 |
2015 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our study expands the mutation spectrum of ALDH5A1 and highlights the importance of molecular genetic evaluation in patients with SSADH deficiency.
|
31117962 |
2019 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency.
|
14635103 |
2003 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare autosomal recessive disorder of γ-aminobutyric acid (GABA) catabolism caused by mutations in the gene coding for succinic semialdehyde dehydrogenase (ALDH5A1).
|
31267348 |
2019 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
Biomarker
|
disease |
CTD_human |
Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.
|
29031482 |
2018 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
Biomarker
|
disease |
BEFREE |
Inherited deficiency of SSADH results in accumulation of the neuromodulator γ-hydroxybutyrate (GHB), which likely contributes to some aspects of the neurological phenotype of SSADH deficiency (MIM #271980).
|
21438145 |
2011 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
Biomarker
|
disease |
CTD_human |
Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.
|
25641190 |
2015 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency.
|
14635103 |
2003 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
SSADH deficiency in an Italian family: a novel ALDH5A1 gene mutation affecting the succinic semialdehyde substrate binding site.
|
28664505 |
2017 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A novel ALDH5A1 mutation is associated with succinic semialdehyde dehydrogenase deficiency and severe intellectual disability in an Iranian family.
|
23825041 |
2013 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Numerous metabolic perturbations unmasked in SSADHD include alterations in oxidative stress parameters, dysregulation of autophagy and mitophagy, dysregulation of both inhibitory and excitatory neurotransmitters and gene expression, and unique subsets of SNP alterations of the SSADH gene (so-called ALDH5A1, or aldehyde dehydrogenase 5A1 gene) on the 6p22 chromosomal arm.
|
27311541 |
2016 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
Biomarker
|
disease |
BEFREE |
We present a patient with Rett syndrome (RTT; MECP2) and autosomal-recessive succinic semialdehyde dehydrogenase deficiency (SSADHD; ALDH5A1 (aldehyde dehydrogenase 5a1 = SSADH), in whom the current phenotype exhibits features of SSADHD (hypotonia, global developmental delay) and RTT (hand stereotypies, gait anomalies).
|
30829465 |
2019 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A study in 2003 described 35 mutations of ALDH5A1 in 54 unrelated families, and the current study and systematic literature review identified nine additional novel mutations in eight unrelated families bringing the total number of unique mutations of ALDH5A1 resulting in SSADH deficiency to 44, and the 44 mutations occur from exon 1 to exon 10.
|
25431891 |
2016 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
Biomarker
|
disease |
CTD_human |
A novel ALDH5A1 mutation is associated with succinic semialdehyde dehydrogenase deficiency and severe intellectual disability in an Iranian family.
|
23825041 |
2013 |
succinic semialdehyde dehydrogenase deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Diagnosis of SSADH deficiency in our patient was established by demonstration of absent enzyme activity in isolated leucocytes, and was associated with a novel missense mutation (c.587G>A; p.Gly196Asp) in the SSADH coding sequence.
|
16545979 |
2006 |